Breast Implant Illness: DNA, Genes, and Uncovering the Hidden Story! #shorts

In this brief interview, Dr. Robert Whitfield discusses the genetic side of breast implant illness (BII). He references a urine inflammation marker as an initial clue, but emphasizes that the most significant insight comes from functional genomics work by Dr. Mansour’s group, with assistance from Kashif. Dr. Whitfield has compiled over 200 genetic reports on BII patients, allowing him to identify recurring patterns of impaired genetic pathways when combined with environmental exposures. He highlights four key immunity‑related pathways that repeatedly appear in these reports: the vitamin D pathway, the methylation pathway, glutathione metabolism, and broader antioxidant pathways. The conversation underscores how recognizing these genetic and environmental patterns can illuminate the underlying mechanisms of BII.










